“…This includes stronger planning and scoping efforts to be incorporated early and regularly in the assessment process, and moving applied genotoxicity testing away from the yes/no testing paradigm and toward a risk assessment approach, including the quantitation of risk of adverse health outcomes, both cancer and noncancer, that can result from genetic damage. The commentary by Ball and Hollnagel briefly reviews the development of and revisions to the Globally Harmonized System (GHS) for Classification and Labeling of chemicals with a focus on the applicability of the GHS assessments, particularly the relevance to genotoxicity to an apical change (i.e., adverse effect) [Ball and Hollnagel, ]. The authors suggest some alternative means of hazard communication and characterization in an effort to provide an inclusive, risk‐based evaluation.…”